Senators Slam FDA And PTO For Patent ‘Oversight Gaps’
‘Lack Of Co-ordination’ Between Authorities Criticized By Hassan And Cassidy
A “lack of co-ordination” between the US FDA and PTO has allowed patent thickets to grow via the granting of flawed patents that do not meet legal requirements, senators Maggie Hassan and Bill Cassidy have complained.
You may also be interested in...
US Senators Urge PTO’s Vidal To Tackle Pharma Patent Thickets
A bipartisan group of senators has written to the US Patent and Trademark Office, urging it to tackle the impact of patent thickets on the generic and biosimilar drug industries.
FDA Airs ‘Concerns’ Over IP Barriers
Senators press for sharing of FDA applications with PTO as Woodcock letter seeks collaboration on everything from PTAB to patent term extensions to ‘possible misuse of the patent system.’
UAE’s Bioventure Is Looking For Partners To Expand
Having recently added to its biosimilars alliance with Alvotech, Dubai-based Bioventure says it is looking to expand its international reach through further partnerships.